{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T03:58:30Z","timestamp":1782791910670,"version":"3.54.5"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-025-01541-w","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T10:40:20Z","timestamp":1738665620000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["TIPS and hepatic encephalopathy in patients with cirrhosis"],"prefix":"10.1007","volume":"40","author":[{"given":"Pauline","family":"Bozon-Rivi\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Rudler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Thabut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"1541_CR1","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/apt.16080","volume":"52","author":"F Artru","year":"2020","unstructured":"Artru F, Miquet X, Azahaf M et al (2020) Consequences of TIPSS placement on the body composition of patients with cirrhosis and severe portal hypertension: a large retrospective CT-based surveillance. Aliment Pharmacol Ther 52:1516\u20131526. https:\/\/doi.org\/10.1111\/apt.16080","journal-title":"Aliment Pharmacol Ther"},{"key":"1541_CR2","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1053\/j.gastro.2016.10.049","volume":"152","author":"J Assaraf","year":"2017","unstructured":"Assaraf J, Weiss N, Thabut D (2017) Proton Pump Inhibitor Administration Triggers Encephalopathy in Cirrhotic patients by modulating blood\u2013brain barrier drug transport. Gastroenterology 152:2077. https:\/\/doi.org\/10.1053\/j.gastro.2016.10.049","journal-title":"Gastroenterology"},{"key":"1541_CR3","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/S0168-8278(01)00185-4","volume":"35","author":"D Azoulay","year":"2001","unstructured":"Azoulay D, Castaing D, Majno P et al (2001) Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol 35:590\u2013597. https:\/\/doi.org\/10.1016\/S0168-8278(01)00185-4","journal-title":"J Hepatol"},{"key":"1541_CR4","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/j.1440-1746.2011.06663.x","volume":"26","author":"M Bai","year":"2011","unstructured":"Bai M, Qi X, Yang Z et al (2011) Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review. J Gastroenterol Hepatol 26:943\u2013951. https:\/\/doi.org\/10.1111\/j.1440-1746.2011.06663.x","journal-title":"J Gastroenterol Hepatol"},{"key":"1541_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/apt.12795","volume":"40","author":"M Bai","year":"2014","unstructured":"Bai M, He C, Yin Z et al (2014) Randomised clinical trial: l -ornithine- l -aspartate reduces significantly the increase of venous ammonia concentration after TIPSS. Aliment Pharmacol Ther 40:63\u201371. https:\/\/doi.org\/10.1111\/apt.12795","journal-title":"Aliment Pharmacol Ther"},{"key":"1541_CR6","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/hep.23128","volume":"50","author":"JS Bajaj","year":"2009","unstructured":"Bajaj JS, Saeian K, Schubert CM et al (2009) Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology 50:1175\u20131183. https:\/\/doi.org\/10.1002\/hep.23128","journal-title":"Hepatology"},{"key":"1541_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.cgh.2016.09.157","volume":"15","author":"JS Bajaj","year":"2017","unstructured":"Bajaj JS, O\u2019Leary JG, Tandon P et al (2017) Hepatic encephalopathy is Associated with mortality in patients with cirrhosis Independent of other extrahepatic organ failures. Clin Gastroenterol Hepatol 15:565\u2013574e4. https:\/\/doi.org\/10.1016\/j.cgh.2016.09.157","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1541_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1572-0241.1998.075_c.x","volume":"93","author":"R Ba\u00f1ares","year":"1998","unstructured":"Ba\u00f1ares R, Casado M, Rodr\u00edguez-L\u00e1iz JM et al (1998) Urgent Transjugular Intrahepatic Portosystemic Shunt for Control of Acute Variceal bleeding. Am J Gastroenterol 93:75\u201379. https:\/\/doi.org\/10.1111\/j.1572-0241.1998.075_c.x","journal-title":"Am J Gastroenterol"},{"key":"1541_CR9","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.14309\/ajg.0000000000000959","volume":"115","author":"A Benmassaoud","year":"2020","unstructured":"Benmassaoud A, Roccarina D, Arico F et al (2020) Sarcopenia does not worsen survival in patients with cirrhosis undergoing Transjugular Intrahepatic Portosystemic Shunt for Refractory ascites. Am J Gastroenterol 115:1911\u20131914. https:\/\/doi.org\/10.14309\/ajg.0000000000000959","journal-title":"Am J Gastroenterol"},{"key":"1541_CR10","doi-asserted-by":"publisher","unstructured":"Berlioux P, Robic MA, Poirson H et al (2014) Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests: Hepatology, Vol. 00, No. 0, 2013. Hepatology 59:622\u2013629. https:\/\/doi.org\/10.1002\/hep.26684","DOI":"10.1002\/hep.26684"},{"key":"1541_CR11","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1111\/apt.13809","volume":"44","author":"D Bettinger","year":"2016","unstructured":"Bettinger D, Schultheiss M, Boettler T et al (2016) Procedural and shunt-related complications and mortality of the transjugular intrahepatic portosystemic shunt (TIPSS). Aliment Pharmacol Ther 44:1051\u20131061. https:\/\/doi.org\/10.1111\/apt.13809","journal-title":"Aliment Pharmacol Ther"},{"key":"1541_CR12","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1016\/j.clnu.2020.09.001","volume":"39","author":"SC Bischoff","year":"2020","unstructured":"Bischoff SC, Bernal W, Dasarathy S et al (2020) ESPEN practical guideline: clinical nutrition in liver disease. Clin Nutr 39:3533\u20133562. https:\/\/doi.org\/10.1016\/j.clnu.2020.09.001","journal-title":"Clin Nutr"},{"key":"1541_CR13","doi-asserted-by":"publisher","first-page":"101593","DOI":"10.1016\/j.clinre.2020.101593","volume":"45","author":"C Bouzbib","year":"2021","unstructured":"Bouzbib C, Cluzel P, Sultanik P et al (2021) Prognosis of patients undergoing salvage TIPS is still poor in the preemptive TIPS era. Clin Res Hepatol Gastroenterol 45:101593. https:\/\/doi.org\/10.1016\/j.clinre.2020.101593","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"1541_CR14","doi-asserted-by":"publisher","first-page":"101784","DOI":"10.1016\/j.clinre.2021.101784","volume":"46","author":"C Bouzbib","year":"2022","unstructured":"Bouzbib C, El Mourabit H, Wendum D et al (2022) ATP-binding cassette transporters expression in rats with cirrhosis and hepatic encephalopathy. Clin Res Hepatol Gastroenterol 46:101784. https:\/\/doi.org\/10.1016\/j.clinre.2021.101784","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"1541_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1053\/j.gastro.2003.11.016","volume":"126","author":"C Bureau","year":"2004","unstructured":"Bureau C, Garcia-Pagan JC, Otal P et al (2004) Improved clinical outcome using polytetrafluoroethylene-coated stents for tips: results of a randomized study. Gastroenterology 126:469\u2013475. https:\/\/doi.org\/10.1053\/j.gastro.2003.11.016","journal-title":"Gastroenterology"},{"key":"1541_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1053\/j.gastro.2016.09.016","volume":"152","author":"C Bureau","year":"2017","unstructured":"Bureau C, Thabut D, Oberti F et al (2017) Transjugular Intrahepatic Portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites. Gastroenterology 152:157\u2013163. https:\/\/doi.org\/10.1053\/j.gastro.2016.09.016","journal-title":"Gastroenterology"},{"key":"1541_CR17","doi-asserted-by":"publisher","first-page":"633","DOI":"10.7326\/M20-0202","volume":"174","author":"C Bureau","year":"2021","unstructured":"Bureau C, Thabut D, Jezequel C et al (2021) The Use of Rifaximin in the Prevention of overt hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt: a Randomized Controlled Trial. Ann Intern Med 174:633\u2013640. https:\/\/doi.org\/10.7326\/M20-0202","journal-title":"Ann Intern Med"},{"key":"1541_CR18","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1053\/gast.1996.v110.pm8608893","volume":"110","author":"J Cabrera","year":"1996","unstructured":"Cabrera J, Maynar M, Granados R et al (1996) Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology 110:832\u2013839. https:\/\/doi.org\/10.1053\/gast.1996.v110.pm8608893","journal-title":"Gastroenterology"},{"key":"1541_CR19","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S0016-5085(98)00640-4","volume":"114","author":"TN Chau","year":"1998","unstructured":"Chau TN, Patch D, Chan YW et al (1998) Salvage Transjugular Intrahepatic Portosystemic shunts: gastric fundal compared with esophageal variceal bleeding. Gastroenterology 114:981\u2013987. https:\/\/doi.org\/10.1016\/S0016-5085(98)00640-4","journal-title":"Gastroenterology"},{"key":"1541_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jhep.2013.10.004","volume":"60","author":"J Cordoba","year":"2014","unstructured":"Cordoba J, Ventura-Cots M, Sim\u00f3n-Talero M et al (2014) Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). J Hepatol 60:275\u2013281. https:\/\/doi.org\/10.1016\/j.jhep.2013.10.004","journal-title":"J Hepatol"},{"key":"1541_CR21","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","volume":"76","author":"R De Franchis","year":"2022","unstructured":"De Franchis R, Bosch J, Garcia-Tsao G et al (2022) Baveno VII\u2013 renewing consensus in portal hypertension. J Hepatol 76:959\u2013974. https:\/\/doi.org\/10.1016\/j.jhep.2021.12.022","journal-title":"J Hepatol"},{"key":"1541_CR22","doi-asserted-by":"publisher","first-page":"e000531","DOI":"10.1136\/bmjgast-2020-000531","volume":"7","author":"K De Wit","year":"2020","unstructured":"De Wit K, Schaapman JJ, Nevens F et al (2020) Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial). BMJ Open Gastroenterol 7:e000531. https:\/\/doi.org\/10.1136\/bmjgast-2020-000531","journal-title":"BMJ Open Gastroenterol"},{"key":"1541_CR23","doi-asserted-by":"publisher","unstructured":"Di Cola S, D\u2019Amico G, Caraceni P et al (2024) Myosteatosis is closely associated with Sarcopenia and significantly worse outcomes in patients with cirrhosis. J Hepatol S0168827824003556. https:\/\/doi.org\/10.1016\/j.jhep.2024.05.020","DOI":"10.1016\/j.jhep.2024.05.020"},{"key":"1541_CR24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/apt.15797","volume":"52","author":"PDJ Dunne","year":"2020","unstructured":"Dunne PDJ, Sinha R, Stanley AJ et al (2020) Randomised clinical trial: standard of care versus early-transjugular intrahepatic porto\u2010systemic shunt (TIPSS) in patients with cirrhosis and oesophageal variceal bleeding. Aliment Pharmacol Ther 52:98\u2013106. https:\/\/doi.org\/10.1111\/apt.15797","journal-title":"Aliment Pharmacol Ther"},{"key":"1541_CR25","doi-asserted-by":"publisher","first-page":"100829","DOI":"10.1016\/j.jhepr.2023.100829","volume":"5","author":"AF Ehrenbauer","year":"2023","unstructured":"Ehrenbauer AF, Schneider H, Stockhoff L et al (2023) Predicting overt hepatic encephalopathy after TIPS: value of three minimal hepatic encephalopathy tests. JHEP Rep 5:100829. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100829","journal-title":"JHEP Rep"},{"key":"1541_CR26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1053\/jhep.2002.30418","volume":"35","author":"\u00c0 Escorsell","year":"2002","unstructured":"Escorsell \u00c0, Ba\u00f1ares R, Garc\u00eda-Pag\u00e1n JC et al (2002) TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial: TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology 35:385\u2013392. https:\/\/doi.org\/10.1053\/jhep.2002.30418","journal-title":"Hepatology"},{"key":"1541_CR27","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.2214\/AJR.09.2968","volume":"193","author":"F Fanelli","year":"2009","unstructured":"Fanelli F, Salvatori FM, Rabuffi P et al (2009) Management of refractory hepatic Encephalopathy after insertion of TIPS: long-term results of Shunt Reduction with Hourglass-shaped balloon-expandable stent-graft. Am J Roentgenol 193:1696\u20131702. https:\/\/doi.org\/10.2214\/AJR.09.2968","journal-title":"Am J Roentgenol"},{"key":"1541_CR28","doi-asserted-by":"publisher","first-page":"101104","DOI":"10.1016\/j.jhepr.2024.101104","volume":"6","author":"SJ Gairing","year":"2024","unstructured":"Gairing SJ, Mangini C, Zarantonello L et al (2024) Proton pump inhibitor use and risk of hepatic encephalopathy: a multicentre study. JHEP Rep 6:101104. https:\/\/doi.org\/10.1016\/j.jhepr.2024.101104","journal-title":"JHEP Rep"},{"key":"1541_CR29","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-5985.23.03422-8","author":"MK Gangwani","year":"2023","unstructured":"Gangwani MK, Ahmed Z, Ishtiaq R et al (2023) Hepatic encephalopathy with proton pump inhibitor use in post tips patients: a systematic review and meta-analysis. Minerva Gastroenterol. https:\/\/doi.org\/10.23736\/S2724-5985.23.03422-8","journal-title":"Minerva Gastroenterol"},{"key":"1541_CR30","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","volume":"362","author":"JC Garc\u00eda-Pag\u00e1n","year":"2010","unstructured":"Garc\u00eda-Pag\u00e1n JC, Caca K, Bureau C et al (2010) Early Use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 362:2370\u20132379. https:\/\/doi.org\/10.1056\/NEJMoa0910102","journal-title":"N Engl J Med"},{"key":"1541_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/hep.510290125","volume":"29","author":"L Garc\u00eda-Villarreal","year":"1999","unstructured":"Garc\u00eda-Villarreal L, Mart\u00ednez-Lagares F, Sierra A et al (1999) Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage: Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic Sclerotherapy for the Prevention of Variceal rebleeding after recent Variceal Hemorrha. Hepatology 29:27\u201332. https:\/\/doi.org\/10.1002\/hep.510290125","journal-title":"Hepatology"},{"key":"1541_CR32","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1023\/A:1026686232756","volume":"43","author":"AL Gerbes","year":"1998","unstructured":"Gerbes AL, Gulberg V, Waggershauser T et al (1998) Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Variceal bleeding in Portal Hypertension (comparison of emergency and elective interventions). Dig Dis Sci 43:2463\u20132469. https:\/\/doi.org\/10.1023\/A:1026686232756","journal-title":"Dig Dis Sci"},{"key":"1541_CR33","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1053\/gast.2002.37073","volume":"123","author":"P Gin\u00e8s","year":"2002","unstructured":"Gin\u00e8s P, Uriz J, Calahorra B et al (2002) Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 123:1839\u20131847. https:\/\/doi.org\/10.1053\/gast.2002.37073","journal-title":"Gastroenterology"},{"key":"1541_CR34","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/liv.14050","volume":"39","author":"S Gioia","year":"2019","unstructured":"Gioia S, Merli M, Nardelli S et al (2019) The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPS. Liver Int 39:871\u2013877. https:\/\/doi.org\/10.1111\/liv.14050","journal-title":"Liver Int"},{"key":"1541_CR35","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.clnu.2022.03.003","volume":"41","author":"S Gioia","year":"2022","unstructured":"Gioia S, Nardelli S, Faccioli J, Ridola L (2022) Post TIPS hepatic encephalopathy: look at muscle and fat! Clin Nutr 41:1150. https:\/\/doi.org\/10.1016\/j.clnu.2022.03.003","journal-title":"Clin Nutr"},{"key":"1541_CR36","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/hep.28598","volume":"64","author":"LL Gluud","year":"2016","unstructured":"Gluud LL, Vilstrup H, Morgan MY (2016) Nonabsorbable disaccharides for hepatic encephalopathy: a systematic review and meta-analysis. Hepatology 64:908\u2013922. https:\/\/doi.org\/10.1002\/hep.28598","journal-title":"Hepatology"},{"key":"1541_CR37","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1080\/003655202317284255","volume":"37","author":"V G\u00fclberg","year":"2002","unstructured":"G\u00fclberg V, Schepke M, Geigenberger G et al (2002) Transjugular Intrahepatic Portosystemic Shunting is not Superior to Endoscopic Variceal Band Ligation for Prevention of Variceal Rebleeding in cirrhotic patients: a Randomized, Controlled Trial. Scand J Gastroenterol 37:338\u2013343. https:\/\/doi.org\/10.1080\/003655202317284255","journal-title":"Scand J Gastroenterol"},{"key":"1541_CR38","unstructured":"Hartl L et al (n.d.) Does encephalopathy with early onset after TIPS impact on mortality? J Hepatol 0"},{"key":"1541_CR39","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1136\/gut.2007.122176","volume":"57","author":"D Haussinger","year":"2008","unstructured":"Haussinger D, Schliess F (2008) Pathogenetic mechanisms of hepatic encephalopathy. Gut 57:1156\u20131165. https:\/\/doi.org\/10.1136\/gut.2007.122176","journal-title":"Gut"},{"key":"1541_CR40","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/hep.30182","volume":"69","author":"V Hern\u00e1ndez-Gea","year":"2019","unstructured":"Hern\u00e1ndez-Gea V, Procopet B, Gir\u00e1ldez \u00c1 et al (2019) Preemptive\u2010TIPS improves outcome in high\u2010risk variceal bleeding: an observational study. Hepatology 69:282\u2013293. https:\/\/doi.org\/10.1002\/hep.30182","journal-title":"Hepatology"},{"key":"1541_CR41","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/hep.28318","volume":"63","author":"IL Holster","year":"2016","unstructured":"Holster IL, Tjwa ETTL, Moelker A et al (2016) Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy\u2009+\u2009\u03b2-blocker for prevention of variceal rebleeding. Hepatology 63:581\u2013589. https:\/\/doi.org\/10.1002\/hep.28318","journal-title":"Hepatology"},{"key":"1541_CR42","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/2050640620952637","volume":"9","author":"A Horhat","year":"2021","unstructured":"Horhat A, Bureau C, Thabut D, Rudler M (2021) Transjugular intrahepatic portosystemic shunt in patients with cirrhosis: indications and posttransjugular intrahepatic portosystemic shunt complications in 2020. United Eur Gastroenterol J 9:203\u2013208. https:\/\/doi.org\/10.1177\/2050640620952637","journal-title":"United Eur Gastroenterol J"},{"key":"1541_CR43","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1002\/hep.510260505","volume":"26","author":"R Jalan","year":"1997","unstructured":"Jalan R, Forrest EH, Stanley AJ et al (1997) A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology 26:1115\u20131122. https:\/\/doi.org\/10.1002\/hep.510260505","journal-title":"Hepatology"},{"key":"1541_CR44","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/hep.23500","volume":"51","author":"P Jepsen","year":"2010","unstructured":"Jepsen P, Ott P, Andersen PK et al (2010) Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology 51:1675\u20131682. https:\/\/doi.org\/10.1002\/hep.23500","journal-title":"Hepatology"},{"key":"1541_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000553.pub2","author":"SA Khan","year":"2006","unstructured":"Khan SA, Tudur Smith C, Williamson PR, Sutton R (2006) Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD000553.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"1541_CR46","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/apt.12803","volume":"40","author":"N Kimer","year":"2014","unstructured":"Kimer N, Krag A, M\u00f8ller S et al (2014) Systematic review with meta-analysis: the effects of rifaximin in hepatic encephalopathy. Aliment Pharmacol Ther 40:123\u2013132. https:\/\/doi.org\/10.1111\/apt.12803","journal-title":"Aliment Pharmacol Ther"},{"key":"1541_CR47","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1136\/gut.2005.089482","volume":"55","author":"N Kochar","year":"2006","unstructured":"Kochar N, Tripathi D, Ireland H et al (2006) Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy. Gut 55:1617\u20131623. https:\/\/doi.org\/10.1136\/gut.2005.089482","journal-title":"Gut"},{"key":"1541_CR48","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jhep.2023.04.028","volume":"79","author":"H Larrue","year":"2023","unstructured":"Larrue H, D\u2019Amico G, Olivas P et al (2023) TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis. J Hepatol 79:692\u2013703. https:\/\/doi.org\/10.1016\/j.jhep.2023.04.028","journal-title":"J Hepatol"},{"key":"1541_CR49","doi-asserted-by":"publisher","unstructured":"Larrue H, Allaire M, Weil-Verhoeven D et al (2024) French guidelines on TIPS: indications and modalities. Liver Int liv 15976. https:\/\/doi.org\/10.1111\/liv.15976","DOI":"10.1111\/liv.15976"},{"key":"1541_CR50","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jhep.2015.03.017","volume":"63","author":"MM Lauridsen","year":"2015","unstructured":"Lauridsen MM, Bajaj JS (2015) Hepatic encephalopathy treatment and its effect on driving abilities: a continental divide. J Hepatol 63:287\u2013288. https:\/\/doi.org\/10.1016\/j.jhep.2015.03.017","journal-title":"J Hepatol"},{"key":"1541_CR51","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jvir.2018.10.015","volume":"30","author":"DS Lewis","year":"2019","unstructured":"Lewis DS, Lee T-H, Konanur M et al (2019) Proton pump inhibitor use is Associated with an increased frequency of New or worsening hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Creation. J Vasc Interv Radiol 30:163\u2013169. https:\/\/doi.org\/10.1016\/j.jvir.2018.10.015","journal-title":"J Vasc Interv Radiol"},{"key":"1541_CR52","doi-asserted-by":"publisher","first-page":"100448","DOI":"10.1016\/j.jhepr.2022.100448","volume":"4","author":"M Li","year":"2022","unstructured":"Li M, Li K, Tang S et al (2022) Restoration of the gut microbiota is associated with a decreased risk of hepatic encephalopathy after TIPS. JHEP Rep 4:100448. https:\/\/doi.org\/10.1016\/j.jhepr.2022.100448","journal-title":"JHEP Rep"},{"key":"1541_CR53","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S2468-1253(19)30090-1","volume":"4","author":"Y Lv","year":"2019","unstructured":"Lv Y, Yang Z, Liu L et al (2019a) Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial. Lancet Gastroenterol Hepatol 4:587\u2013598. https:\/\/doi.org\/10.1016\/S2468-1253(19)30090-1","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1541_CR54","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1136\/gutjnl-2018-317057","volume":"68","author":"Y Lv","year":"2019","unstructured":"Lv Y, Zuo L, Zhu X et al (2019b) Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study. Gut 68:1297\u20131310. https:\/\/doi.org\/10.1136\/gutjnl-2018-317057","journal-title":"Gut"},{"key":"1541_CR55","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/hep.32453","volume":"76","author":"Y Lv","year":"2022","unstructured":"Lv Y, Chen H, Luo B et al (2022) Concurrent large spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after TIPS: a randomized controlled trial. Hepatology 76:676\u2013688. https:\/\/doi.org\/10.1002\/hep.32453","journal-title":"Hepatology"},{"key":"1541_CR56","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2214\/AJR.05.1250","volume":"188","author":"G Maleux","year":"2007","unstructured":"Maleux G, Verslype C, Heye S et al (2007) Endovascular shunt reduction in the management of Transjugular Portosystemic Shunt-Induced hepatic encephalopathy: preliminary experience with reduction stents and stent-grafts. Am J Roentgenol 188:659\u2013664. https:\/\/doi.org\/10.2214\/AJR.05.1250","journal-title":"Am J Roentgenol"},{"key":"1541_CR57","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/hep.510270109","volume":"27","author":"M Merli","year":"1998","unstructured":"Merli M, Salerno F, Riggio O et al (1998) Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Hepatology 27:48\u201353. https:\/\/doi.org\/10.1002\/hep.510270109","journal-title":"Hepatology"},{"key":"1541_CR58","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jhep.2018.06.024","volume":"70","author":"M Merli","year":"2019","unstructured":"Merli M, Berzigotti A, Zelber-Sagi S et al (2019) EASL Clinical Practice guidelines on nutrition in chronic liver disease. J Hepatol 70:172\u2013193. https:\/\/doi.org\/10.1016\/j.jhep.2018.06.024","journal-title":"J Hepatol"},{"key":"1541_CR59","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1002\/hep.20386","volume":"40","author":"A Monescillo","year":"2004","unstructured":"Monescillo A, Mart\u00ednez-Lagares F, Ruiz-del-Arbol L et al (2004) Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 40:793\u2013801. https:\/\/doi.org\/10.1002\/hep.20386","journal-title":"Hepatology"},{"key":"1541_CR60","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.jhep.2022.06.001","volume":"77","author":"S Montagnese","year":"2022","unstructured":"Montagnese S, Rautou P-E, Romero-G\u00f3mez M et al (2022) EASL Clinical Practice guidelines on the management of hepatic encephalopathy. J Hepatol 77:807\u2013824. https:\/\/doi.org\/10.1016\/j.jhep.2022.06.001","journal-title":"J Hepatol"},{"key":"1541_CR61","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1386-6346(01)00104-8","volume":"21","author":"Y Narahara","year":"2001","unstructured":"Narahara Y (2001) A randomized clinical trial comparing transjugular intrahepatic portosystemic shunt with endoscopic sclerotherapy in the long-term management of patients with cirrhosis after recent variceal hemorrhage. Hepatol Res 21:189\u2013198. https:\/\/doi.org\/10.1016\/S1386-6346(01)00104-8","journal-title":"Hepatol Res"},{"key":"1541_CR62","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00535-010-0282-9","volume":"46","author":"Y Narahara","year":"2011","unstructured":"Narahara Y, Kanazawa H, Fukuda T et al (2011) Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial. J Gastroenterol 46:78\u201385. https:\/\/doi.org\/10.1007\/s00535-010-0282-9","journal-title":"J Gastroenterol"},{"key":"1541_CR63","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/ajg.2016.29","volume":"111","author":"S Nardelli","year":"2016","unstructured":"Nardelli S, Gioia S, Pasquale C et al (2016) Cognitive impairment predicts the occurrence of hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt. Am J Gastroenterol 111:523\u2013528. https:\/\/doi.org\/10.1038\/ajg.2016.29","journal-title":"Am J Gastroenterol"},{"key":"1541_CR64","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cgh.2016.10.028","volume":"15","author":"S Nardelli","year":"2017","unstructured":"Nardelli S, Lattanzi B, Torrisi S et al (2017) Sarcopenia is risk factor for development of hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Placement. Clin Gastroenterol Hepatol 15:934\u2013936. https:\/\/doi.org\/10.1016\/j.cgh.2016.10.028","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1541_CR65","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1002\/hep.30692","volume":"70","author":"S Nardelli","year":"2019","unstructured":"Nardelli S, Lattanzi B, Merli M et al (2019) Muscle alterations are Associated with minimal and overt hepatic encephalopathy in patients with liver cirrhosis. Hepatology 70:1704\u20131713. https:\/\/doi.org\/10.1002\/hep.30692","journal-title":"Hepatology"},{"key":"1541_CR66","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1148\/radiol.2021203051","volume":"299","author":"S Nardelli","year":"2021","unstructured":"Nardelli S, Riggio O, Turco L et al (2021) Relevance of spontaneous portosystemic shunts detected with CT in patients with cirrhosis. Radiology 299:133\u2013140. https:\/\/doi.org\/10.1148\/radiol.2021203051","journal-title":"Radiology"},{"key":"1541_CR67","doi-asserted-by":"publisher","unstructured":"Nardelli S, Riggio O, Marra F et al (2023) Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis. J Hepatol S0168827823053102. https:\/\/doi.org\/10.1016\/j.jhep.2023.11.033","DOI":"10.1016\/j.jhep.2023.11.033"},{"key":"1541_CR68","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1148\/radiology.205.1.9314981","volume":"205","author":"GK Nazarian","year":"1997","unstructured":"Nazarian GK, Bjarnason H, Dietz CA et al (1997) Refractory ascites: midterm results of treatment with a transjugular intrahepatic portosystemic shunt. Radiology 205:173\u2013180. https:\/\/doi.org\/10.1148\/radiology.205.1.9314981","journal-title":"Radiology"},{"key":"1541_CR69","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1007\/s10620-017-4630-y","volume":"62","author":"G Pantham","year":"2017","unstructured":"Pantham G, Post A, Venkat D et al (2017) A New look at precipitants of overt hepatic encephalopathy in cirrhosis. Dig Dis Sci 62:2166\u20132173. https:\/\/doi.org\/10.1007\/s10620-017-4630-y","journal-title":"Dig Dis Sci"},{"key":"1541_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/398172","volume":"2013","author":"P Peter","year":"2013","unstructured":"Peter P, Andrej Z, Katarina \u0160P et al (2013) Hepatic encephalopathy after Transjugular Intrahepatic Portosystemic Shunt in patients with recurrent Variceal Hemorrhage. Gastroenterol Res Pract 2013:1\u20135. https:\/\/doi.org\/10.1155\/2013\/398172","journal-title":"Gastroenterol Res Pract"},{"key":"1541_CR71","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jhep.2003.10.011","volume":"40","author":"M Plauth","year":"2004","unstructured":"Plauth M, Sch\u00fctz T, Buckendahl DP et al (2004) Weight gain after transjugular intrahepatic portosystemic shunt is associated with improvement in body composition in malnourished patients with cirrhosis and hypermetabolism. J Hepatol 40:228\u2013233. https:\/\/doi.org\/10.1016\/j.jhep.2003.10.011","journal-title":"J Hepatol"},{"key":"1541_CR72","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1016\/j.jhep.2019.12.021","volume":"72","author":"M Praktiknjo","year":"2020","unstructured":"Praktiknjo M, Sim\u00f3n-Talero M, R\u00f6mer J et al (2020) Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis. J Hepatol 72:1140\u20131150. https:\/\/doi.org\/10.1016\/j.jhep.2019.12.021","journal-title":"J Hepatol"},{"key":"1541_CR73","doi-asserted-by":"publisher","first-page":"100264","DOI":"10.1016\/j.jhepr.2021.100264","volume":"3","author":"M Praktiknjo","year":"2021","unstructured":"Praktiknjo M, Abu-Omar J, Chang J et al (2021) Controlled underdilation using novel VIATORR\u00ae controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation. JHEP Rep 3:100264. https:\/\/doi.org\/10.1016\/j.jhepr.2021.100264","journal-title":"JHEP Rep"},{"key":"1541_CR74","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/1756283X16671286","volume":"10","author":"X Qi","year":"2017","unstructured":"Qi X, Tian Y, Zhang W et al (2017) Covered versus bare stents for transjugular intrahepatic portosystemic shunt: an updated meta-analysis of randomized controlled trials. Ther Adv Gastroenterol 10:32\u201341. https:\/\/doi.org\/10.1177\/1756283X16671286","journal-title":"Ther Adv Gastroenterol"},{"key":"1541_CR75","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.jhep.2004.12.028","volume":"42","author":"O Riggio","year":"2005","unstructured":"Riggio O, Masini A, Efrati C et al (2005) Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study. J Hepatol 42:674\u2013679. https:\/\/doi.org\/10.1016\/j.jhep.2004.12.028","journal-title":"J Hepatol"},{"key":"1541_CR76","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1111\/j.1572-0241.2008.02102.x","volume":"103","author":"O Riggio","year":"2008","unstructured":"Riggio O, Angeloni S, Salvatori FM et al (2008) Incidence, natural history, and risk factors of hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt with polytetrafluoroethylene-covered stent grafts. Am J Gastroenterol 103:2738\u20132746. https:\/\/doi.org\/10.1111\/j.1572-0241.2008.02102.x","journal-title":"Am J Gastroenterol"},{"key":"1541_CR77","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jhep.2010.02.033","volume":"53","author":"O Riggio","year":"2010","unstructured":"Riggio O, Ridola L, Angeloni S et al (2010) Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial. J Hepatol 53:267\u2013272. https:\/\/doi.org\/10.1016\/j.jhep.2010.02.033","journal-title":"J Hepatol"},{"key":"1541_CR78","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cld.2011.12.008","volume":"16","author":"O Riggio","year":"2012","unstructured":"Riggio O, Nardelli S, Moscucci F et al (2012) Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt. Clin Liver Dis 16:133\u2013146. https:\/\/doi.org\/10.1016\/j.cld.2011.12.008","journal-title":"Clin Liver Dis"},{"key":"1541_CR79","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/ajg.2010.413","volume":"106","author":"E Rom\u00e1n","year":"2011","unstructured":"Rom\u00e1n E, C\u00f3rdoba J, Torrens M et al (2011) Minimal hepatic encephalopathy is Associated with Falls. Am J Gastroenterol 106:476\u2013482. https:\/\/doi.org\/10.1038\/ajg.2010.413","journal-title":"Am J Gastroenterol"},{"key":"1541_CR80","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.3748\/wjg.v12.i15.2406","volume":"12","author":"M Romero-G\u00f3mez","year":"2006","unstructured":"Romero-G\u00f3mez M (2006) Phosphate-activated glutaminase activity is enhanced in brain, intestine and kidneys of rats following portacaval anastomosis. World J Gastroenterol 12:2406. https:\/\/doi.org\/10.3748\/wjg.v12.i15.2406","journal-title":"World J Gastroenterol"},{"key":"1541_CR81","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S0140-6736(96)08189-5","volume":"349","author":"M R\u00f6ssle","year":"1997","unstructured":"R\u00f6ssle M, Deibert P, Haag K et al (1997) Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 349:1043\u20131049. https:\/\/doi.org\/10.1016\/S0140-6736(96)08189-5","journal-title":"Lancet"},{"key":"1541_CR82","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1056\/NEJM200006083422303","volume":"342","author":"M R\u00f6ssle","year":"2000","unstructured":"R\u00f6ssle M, Ochs A, G\u00fclberg V et al (2000) A comparison of Paracentesis and Transjugular Intrahepatic Portosystemic Shunting in patients with ascites. N Engl J Med 342:1701\u20131707. https:\/\/doi.org\/10.1056\/NEJM200006083422303","journal-title":"N Engl J Med"},{"key":"1541_CR83","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00270-018-1992-2","volume":"41","author":"MW Rowley","year":"2018","unstructured":"Rowley MW, Choi M, Chen S et al (2018) Refractory hepatic Encephalopathy after Elective Transjugular Intrahepatic Portosystemic Shunt: risk factors and outcomes with revision. Cardiovasc Intervent Radiol 41:1765\u20131772. https:\/\/doi.org\/10.1007\/s00270-018-1992-2","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1541_CR84","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/apt.12934","volume":"40","author":"M Rudler","year":"2014","unstructured":"Rudler M, Cluzel P, Corvec TL et al (2014) Early-TIPSS placement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival. Aliment Pharmacol Ther 40:1074\u20131080. https:\/\/doi.org\/10.1111\/apt.12934","journal-title":"Aliment Pharmacol Ther"},{"key":"1541_CR85","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/liv.13632","volume":"38","author":"M Rudler","year":"2018","unstructured":"Rudler M, Bureau C, Carbonell N et al (2018a) Recalibrated MELD and hepatic encephalopathy are prognostic factors in cirrhotic patients with acute variceal bleeding. Liver Int 38:469\u2013476. https:\/\/doi.org\/10.1111\/liv.13632","journal-title":"Liver Int"},{"key":"1541_CR86","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/apt.14938","volume":"48","author":"M Rudler","year":"2018","unstructured":"Rudler M, Weiss N, Perlbarg V et al (2018b) Combined diffusion tensor imaging and magnetic resonance spectroscopy to predict neurological outcome before transjugular intrahepatic portosystemic shunt. Aliment Pharmacol Ther 48:863\u2013874. https:\/\/doi.org\/10.1111\/apt.14938","journal-title":"Aliment Pharmacol Ther"},{"key":"1541_CR87","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.jhep.2021.05.012","volume":"75","author":"M Rudler","year":"2021","unstructured":"Rudler M, Savier E, Alioua I et al (2021) TIPS and liver transplantation should always be discussed together. J Hepatol 75:1000\u20131001. https:\/\/doi.org\/10.1016\/j.jhep.2021.05.012","journal-title":"J Hepatol"},{"key":"1541_CR88","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1136\/gutjnl-2022-326975","volume":"72","author":"M Rudler","year":"2023","unstructured":"Rudler M, Hern\u00e1ndez-Gea V, Procopet BD et al (2023a) Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding. Gut 72:749\u2013758. https:\/\/doi.org\/10.1136\/gutjnl-2022-326975","journal-title":"Gut"},{"key":"1541_CR89","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/apt.17322","volume":"57","author":"M Rudler","year":"2023","unstructured":"Rudler M, Hernandez-Gea V, Thabut D, Garcia\u2010Pagan J (2023b) Letter: improve survival after variceal bleeding in cirrhosis\u2014place p TIPS as early as possible after index bleed. Aliment Pharmacol Ther 57:439\u2013440. https:\/\/doi.org\/10.1111\/apt.17322","journal-title":"Aliment Pharmacol Ther"},{"key":"1541_CR90","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/hep.20364","volume":"40","author":"F Salerno","year":"2004","unstructured":"Salerno F, Merli M, Riggio O et al (2004) Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites. Hepatology 40:629\u2013635. https:\/\/doi.org\/10.1002\/hep.20364","journal-title":"Hepatology"},{"key":"1541_CR91","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1053\/j.gastro.2007.06.020","volume":"133","author":"F Salerno","year":"2007","unstructured":"Salerno F, Camm\u00e0 C, Enea M et al (2007) Transjugular Intrahepatic Portosystemic Shunt for Refractory ascites: a Meta-analysis of individual Patient Data. Gastroenterology 133:825\u2013834. https:\/\/doi.org\/10.1053\/j.gastro.2007.06.020","journal-title":"Gastroenterology"},{"key":"1541_CR92","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1053\/gast.1996.v111.pm8698192","volume":"111","author":"A Sanyal","year":"1996","unstructured":"Sanyal A, Freedman A, Luketic V et al (1996) Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology 111:138\u2013146. https:\/\/doi.org\/10.1053\/gast.1996.v111.pm8698192","journal-title":"Gastroenterology"},{"key":"1541_CR93","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1053\/gast.2003.50088","volume":"124","author":"AJ Sanyal","year":"2003","unstructured":"Sanyal AJ, Genning C, Reddy KR et al (2003) The north American study for the treatment of Refractory ascites. Gastroenterology 124:634\u2013641. https:\/\/doi.org\/10.1053\/gast.2003.50088","journal-title":"Gastroenterology"},{"key":"1541_CR94","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.2214\/AJR.19.22497","volume":"216","author":"A Sarwar","year":"2021","unstructured":"Sarwar A, Esparaz AM, Chakrala N et al (2021) Efficacy of TIPS reduction for refractory hepatic Encephalopathy, Right Heart failure, and Liver Dysfunction. Am J Roentgenol 216:1267\u20131272. https:\/\/doi.org\/10.2214\/AJR.19.22497","journal-title":"Am J Roentgenol"},{"key":"1541_CR95","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1055\/s-2002-33565","volume":"34","author":"P Sauer","year":"2002","unstructured":"Sauer P, Hansmann J, Richter GM et al (2002) Endoscopic Variceal Ligation plus Propranolol vs. Transjugular Intrahepatic Portosystemic Stent Shunt: a long-term Randomized Trial. Endoscopy 34:690\u2013697. https:\/\/doi.org\/10.1055\/s-2002-33565","journal-title":"Endoscopy"},{"key":"1541_CR96","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1053\/j.gastro.2015.05.011","volume":"149","author":"T Sauerbruch","year":"2015","unstructured":"Sauerbruch T, Mengel M, Dollinger M et al (2015) Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents Versus Hemodynamically Controlled Medical Therapy. Gastroenterology 149:660\u2013668e1. https:\/\/doi.org\/10.1053\/j.gastro.2015.05.011","journal-title":"Gastroenterology"},{"key":"1541_CR97","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.cgh.2018.01.029","volume":"16","author":"F Schepis","year":"2018","unstructured":"Schepis F, Vizzutti F, Garcia-Tsao G et al (2018) Under-dilated TIPS associate with efficacy and reduced Encephalopathy in a Prospective, non-randomized study of patients with cirrhosis. Clin Gastroenterol Hepatol 16:1153\u20131162e7. https:\/\/doi.org\/10.1016\/j.cgh.2018.01.029","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"20","key":"1541_CR98","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.3390\/jcm10204763","volume":"10","author":"LL Seifert","year":"2021","unstructured":"Seifert LL, Schindler P, Schoster M, Weller JF, Wilms C, Schmidt HH, Maschmeier M, Masthoff M, K\u00f6hler M, Heinzow H, Wildgruber M (2021) Recurrence of hepatic encephalopathy after TIPS: Effective prophylaxis with combination of lactulose and rifaximin. J Clin Med 10(20):4763. https:\/\/doi.org\/10.3390\/jcm10204763","journal-title":"J Clin Med"},{"key":"1541_CR99","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1007\/s11011-019-00490-5","volume":"34","author":"M Senzolo","year":"2019","unstructured":"Senzolo M, Zarantonello L, Formentin C et al (2019) Predictive value of induced hyperammonaemia and neuropsychiatric profiling in relation to the occurrence of post-TIPS hepatic encephalopathy. Metab Brain Dis 34:1803\u20131812. https:\/\/doi.org\/10.1007\/s11011-019-00490-5","journal-title":"Metab Brain Dis"},{"key":"1541_CR100","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.jvir.2022.08.007","volume":"33","author":"RJ Shah","year":"2022","unstructured":"Shah RJ, Alqadi MM, Duvvuri M et al (2022) Clinical outcomes and Patency after Transjugular Intrahepatic Portosystemic Shunt reduction for overshunting adverse events. J Vasc Interv Radiol 33:1507\u20131512. https:\/\/doi.org\/10.1016\/j.jvir.2022.08.007","journal-title":"J Vasc Interv Radiol"},{"key":"1541_CR101","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1053\/j.gastro.2018.01.028","volume":"154","author":"M Sim\u00f3n-Talero","year":"2018","unstructured":"Sim\u00f3n-Talero M, Roccarina D, Mart\u00ednez J et al (2018) Association between Portosystemic shunts and increased complications and mortality in patients with cirrhosis. Gastroenterology 154:1694\u20131705e4. https:\/\/doi.org\/10.1053\/j.gastro.2018.01.028","journal-title":"Gastroenterology"},{"key":"1541_CR102","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/lt.21129","volume":"13","author":"CA Stewart","year":"2007","unstructured":"Stewart CA, Malinchoc M, Kim WR, Kamath PS (2007) Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl 13:1366\u20131371. https:\/\/doi.org\/10.1002\/lt.21129","journal-title":"Liver Transpl"},{"key":"1541_CR103","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1177\/2050640618795928","volume":"6","author":"L Sturm","year":"2018","unstructured":"Sturm L, Bettinger D, Giesler M et al (2018) Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS). United Eur Gastroenterol J 6:1380\u20131390. https:\/\/doi.org\/10.1177\/2050640618795928","journal-title":"United Eur Gastroenterol J"},{"key":"1541_CR104","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jhep.2017.09.002","volume":"68","author":"D Thabut","year":"2018","unstructured":"Thabut D, Pauwels A, Carbonell N et al (2018) Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: a large multicentre audit with real-life results. J Hepatol 68:73\u201381. https:\/\/doi.org\/10.1016\/j.jhep.2017.09.002","journal-title":"J Hepatol"},{"key":"1541_CR105","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/liv.15510","volume":"43","author":"D Thabut","year":"2023","unstructured":"Thabut D, Bouzbib C, Meunier L et al (2023) Diagnosis and management of hepatic encephalopathy: the French recommendations. Liver Int 43:750\u2013762. https:\/\/doi.org\/10.1111\/liv.15510","journal-title":"Liver Int"},{"key":"1541_CR106","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00535-009-0099-6","volume":"44","author":"U Thalheimer","year":"2009","unstructured":"Thalheimer U, Leandro G, Samonakis DN et al (2009) TIPS for refractory ascites: a single-centre experience. J Gastroenterol 44:1089\u20131095. https:\/\/doi.org\/10.1007\/s00535-009-0099-6","journal-title":"J Gastroenterol"},{"key":"1541_CR107","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1053\/j.gastro.2016.09.007","volume":"152","author":"C-F Tsai","year":"2017","unstructured":"Tsai C-F, Chen M-H, Wang Y-P et al (2017) Proton Pump inhibitors increase risk for hepatic encephalopathy in patients with cirrhosis in a Population Study. Gastroenterology 152:134\u2013141. https:\/\/doi.org\/10.1053\/j.gastro.2016.09.007","journal-title":"Gastroenterology"},{"key":"1541_CR108","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/hep.510230507","volume":"23","author":"P Van Der Linden","year":"1996","unstructured":"Van Der Linden P, Le Moine O, Ghysels M et al (1996) Pulmonary hypertension after transjugular intrahepatic portosystemic shunt: effects on right ventricular function. Hepatology 23:982\u2013987. https:\/\/doi.org\/10.1002\/hep.510230507","journal-title":"Hepatology"},{"key":"1541_CR109","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/hep.27210","volume":"60","author":"H Vilstrup","year":"2014","unstructured":"Vilstrup H, Amodio P, Bajaj J et al (2014) Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the study of Liver diseases and the European Association for the study of the liver: Vilstrup et al. Hepatology 60:715\u2013735. https:\/\/doi.org\/10.1002\/hep.27210","journal-title":"Hepatology"},{"key":"1541_CR110","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1136\/gut.2008.172486","volume":"58","author":"F Vizzutti","year":"2009","unstructured":"Vizzutti F, Arena U, Rega L et al (2009) Liver failure complicating segmental hepatic ischaemia induced by a PTFE-coated TIPS stent. Gut 58:582\u2013584. https:\/\/doi.org\/10.1136\/gut.2008.172486","journal-title":"Gut"},{"key":"1541_CR111","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/hep.32704","volume":"77","author":"F Vizzutti","year":"2023","unstructured":"Vizzutti F, Celsa C, Calvaruso V et al (2023) Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: a validated prediction model. Hepatology 77:476\u2013488. https:\/\/doi.org\/10.1002\/hep.32704","journal-title":"Hepatology"},{"key":"1541_CR112","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1002\/hep.31913","volume":"74","author":"A Walter","year":"2021","unstructured":"Walter A, Rudler M, Olivas P et al (2021) Combination of Model for End-Stage Liver Disease and Lactate predicts death in patients treated with salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal bleeding. Hepatology 74:2085\u20132101. https:\/\/doi.org\/10.1002\/hep.31913","journal-title":"Hepatology"},{"key":"1541_CR113","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jhep.2017.05.006","volume":"67","author":"Q Wang","year":"2017","unstructured":"Wang Q, Lv Y, Bai M et al (2017) Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding. J Hepatol 67:508\u2013516. https:\/\/doi.org\/10.1016\/j.jhep.2017.05.006","journal-title":"J Hepatol"},{"key":"1541_CR114","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.jhep.2016.07.046","volume":"65","author":"N Weiss","year":"2016","unstructured":"Weiss N, Barbier Saint Hilaire P, Colsch B et al (2016) Cerebrospinal fluid metabolomics highlights dysregulation of energy metabolism in overt hepatic encephalopathy. J Hepatol 65:1120\u20131130. https:\/\/doi.org\/10.1016\/j.jhep.2016.07.046","journal-title":"J Hepatol"},{"key":"1541_CR115","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00134-017-4845-6","volume":"44","author":"N Weiss","year":"2018","unstructured":"Weiss N, Jalan R, Thabut D (2018) Understanding hepatic encephalopathy. Intensive Care Med 44:231\u2013234. https:\/\/doi.org\/10.1007\/s00134-017-4845-6","journal-title":"Intensive Care Med"},{"key":"1541_CR116","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s11596-017-1760-6","volume":"37","author":"H Zhang","year":"2017","unstructured":"Zhang H, Zhang H, Li H et al (2017) TIPS versus endoscopic therapy for variceal rebleeding in cirrhosis: a meta-analysis update. J Huazhong Univ Sci Technolog Med Sci 37:475\u2013485. https:\/\/doi.org\/10.1007\/s11596-017-1760-6","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"1541_CR117","doi-asserted-by":"publisher","first-page":"e260","DOI":"10.1016\/j.jhep.2023.12.014","volume":"80","author":"F Zhang","year":"2024","unstructured":"Zhang F, Zhang M, Wang L, Zhuge Y (2024) Hepatic encephalopathy and survival after transjugular intrahepatic portosystemic shunt: do spontaneous portosystemic shunts matter? J Hepatol 80:e260\u2013e261. https:\/\/doi.org\/10.1016\/j.jhep.2023.12.014","journal-title":"J Hepatol"},{"key":"1541_CR118","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1097\/CM9.0000000000000212","volume":"132","author":"G-P Zhou","year":"2019","unstructured":"Zhou G-P, Sun L-Y, Wei L et al (2019) Comparision between portosystemic shunts and endoscopic therapy for prevention of variceal re-bleeding: a systematic review and meta-analysis. Chin Med J (Engl) 132:1087\u20131099. https:\/\/doi.org\/10.1097\/CM9.0000000000000212","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"1541_CR119","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1007\/s11605-019-04146-8","volume":"23","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Wang X, Xi X, Li X, Luo X, Yang L (2019) Emergency transjugular intrahepatic portosystemic shunt: An effective and safe treatment for uncontrolled variceal bleeding. J Gastrointest Surg 23(11):2193\u20132200. https:\/\/doi.org\/10.1007\/s11605-019-04146-8","journal-title":"J Gastrointest Surg"},{"key":"1541_CR120","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jvir.2018.08.023","volume":"30","author":"L Zuo","year":"2019","unstructured":"Zuo L, Lv Y, Wang Q et al (2019) Early-recurrent overt hepatic encephalopathy is Associated with reduced survival in cirrhotic patients after Transjugular Intrahepatic Portosystemic Shunt Creation. J Vasc Interv Radiol 30:148\u2013153e2. https:\/\/doi.org\/10.1016\/j.jvir.2018.08.023","journal-title":"J Vasc Interv Radiol"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01541-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-025-01541-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01541-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T09:06:12Z","timestamp":1740819972000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-025-01541-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":120,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["1541"],"URL":"https:\/\/doi.org\/10.1007\/s11011-025-01541-w","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"6 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Pauline Bozon-Rivi\u00e8re and Nicolas Weiss have no conflict of interestMarika Rudler gives conferences for Gore and Dominique Thabut is consultant and gives conferences for Gore, Alfasigma, Abbvie and Gilead.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"117"}}